Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Israel · Delayed Price · Currency is ILS · Price in ILA 198.00
0.00 (0.00%)
Aug 12, 2026, 11:06 AM IDT
TLV:TKUN Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.03 | 0.16 | 6.64 | 1.76 | 13.42 |
Cash & Short-Term Investments | 0.03 | 0.16 | 6.64 | 1.76 | 13.42 |
Cash Growth | -81.25% | -97.59% | 278.36% | -86.91% | 21.58% |
Accounts Receivable | - | 3.92 | 5.72 | 12.91 | 9.71 |
Other Receivables | 0.45 | 0.09 | 0.18 | 0.07 | 0.45 |
Receivables | 0.45 | 4.01 | 5.89 | 12.98 | 10.16 |
Inventory | 0.1 | 1.26 | 9.84 | 21.11 | 15.04 |
Prepaid Expenses | 0.17 | 0.55 | 0.28 | - | - |
Other Current Assets | 0.54 | 0.5 | 1.44 | 7.62 | 4.31 |
Total Current Assets | 1.29 | 6.48 | 24.1 | 43.46 | 42.93 |
Property, Plant & Equipment | 0.21 | 7.31 | 29.41 | 69.21 | 77.89 |
Long-Term Investments | - | - | 4.73 | 6.93 | 1.16 |
Goodwill | - | - | - | 1.34 | 18.91 |
Other Intangible Assets | - | 9.81 | 18.34 | 35.89 | 48.9 |
Other Long-Term Assets | - | 0.41 | - | - | - |
Total Assets | 1.5 | 24.01 | 76.57 | 156.83 | 189.78 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.05 | 1.14 | 3.56 | 6.99 | 5.27 |
Accrued Expenses | 5.66 | 6.63 | 8.5 | 6.06 | 5.82 |
Short-Term Debt | 11.88 | 10.74 | 12.52 | 10.01 | 10.2 |
Current Portion of Long-Term Debt | - | - | - | - | 0.07 |
Current Portion of Leases | 0.23 | 0.56 | 1.09 | 1.74 | 1.57 |
Current Unearned Revenue | - | - | - | 1.52 | - |
Other Current Liabilities | - | 0.87 | 2.66 | 0.88 | 0.04 |
Total Current Liabilities | 20.83 | 19.94 | 28.33 | 27.21 | 22.97 |
Long-Term Debt | 1.48 | 1.45 | 1.48 | 1.48 | 1.56 |
Long-Term Leases | 0.16 | 3.5 | 4.98 | 6.03 | 6.45 |
Other Long-Term Liabilities | - | 4.47 | 8.74 | 5.19 | 14.98 |
Total Liabilities | 22.46 | 29.36 | 43.53 | 39.9 | 45.96 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Additional Paid-In Capital | 277.66 | 277.46 | 275.74 | 265.61 | 244.31 |
Retained Earnings | -290.83 | -274.97 | -234.87 | -145.99 | -97.75 |
Total Common Equity | -13.17 | 2.48 | 40.87 | 119.62 | 146.56 |
Minority Interest | -7.8 | -7.83 | -7.83 | -2.7 | -2.73 |
Shareholders' Equity | -20.97 | -5.35 | 33.04 | 116.92 | 143.82 |
Total Liabilities & Equity | 1.5 | 24.01 | 76.57 | 156.83 | 189.78 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 13.75 | 16.25 | 20.06 | 19.26 | 19.85 |
Net Cash (Debt) | -13.72 | -16.09 | -13.42 | -17.5 | -6.43 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -16.15 | -19.21 | -21.29 | -35.98 | -15.31 |
Filing Date Shares Outstanding | 0.85 | 0.85 | 0.81 | 0.57 | 0.45 |
Total Common Shares Outstanding | 0.85 | 0.85 | 0.81 | 0.57 | 0.45 |
Working Capital | -19.54 | -13.46 | -4.23 | 16.25 | 19.95 |
Book Value Per Share | -15.50 | 2.92 | 50.51 | 211.29 | 325.82 |
Tangible Book Value | -13.17 | -7.33 | 22.53 | 82.39 | 78.76 |
Tangible Book Value Per Share | -15.50 | -8.62 | 27.85 | 145.53 | 175.09 |
Buildings | - | 56.49 | 56.49 | 56.35 | 54.22 |
Machinery | - | 4.45 | 4.44 | 4.51 | 4.63 |